This inventor holds 9 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Oklahoma Medical Research Foundation, Isogenis, Inc., Colorado Seminary. Active years: 2003-2017.
Company Filing History:
4 out of 200 
3 out of 3 
1 out of 22 
Years Active: 2003-2017
Title: The Innovative Contributions of Miles B Brennan in Gene Therapy
Introduction
Miles B Brennan, an accomplished inventor based in Denver, CO, has significantly advanced the field of gene therapy through his innovative inventions. With a remarkable portfolio comprising nine patents, Brennan's work is pivotal in the ongoing evolution of medical technology. His latest patents focus on the construction of fully-deleted adenovirus-based gene delivery vectors, showcasing his commitment to improving therapeutic solutions for various medical conditions.
Latest Patents
Brennan's latest patent, entitled "Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof", emphasizes the development of adenovirus-based gene delivery systems devoid of helper adenovirus. The disclosed embodiments address key applications in gene therapy, including gene and protein expression, vaccine development, and immunosuppressive therapy for allogeneic transplantation. The innovative methodology begins by providing an adenovirus packaging cell line, followed by the transfection of a fully-deleted adenoviral vector construct. This remarkable approach enables the encapsidation of a fully-deleted adenoviral vector independent of helper adenovirus, thereby improving the efficiency and safety of gene delivery to target cells for therapeutic purposes.
Career Highlights
Throughout his career, Miles B Brennan has collaborated with significant research institutions, including the Oklahoma Medical Research Foundation and Isogenis, Inc. His work has not only expanded the horizons of gene therapy but has also paved the way for new therapeutic options that benefit patients suffering from various conditions.
Collaborations
Collaboration has been a cornerstone of Brennan’s success, as evidenced by his partnerships with esteemed colleagues such as Ute H Hochgeschwender and Erin K Spiegel. These collaborations foster an environment of innovation and discovery, emphasizing teamwork in the pursuit of groundbreaking solutions in biotechnology.
Conclusion
Miles B Brennan exemplifies the spirit of innovation in the field of gene therapy. His nine patents and comprehensive research contribute to a better understanding of gene delivery systems, ultimately impacting the landscape of modern medicine. As the field continues to evolve, the significance of his contributions will undoubtedly inspire future advancements in therapeutic interventions.